Literature DB >> 2462300

Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy.

M Caine1.   

Abstract

Smooth muscle tone in the enlarged prostate is directly related to stimulation of the alpha-adrenergic receptors present in prostatic tissue. Variations in tone produce corresponding alterations in the degree of prostatic obstruction. Such variations can explain the spontaneous symptomatic variations seen clinically in benign prostatic hypertrophy (BPH), and represent a "dynamic component" in obstruction which is superimposed on the underlying basic "mechanical component." The obstructive symptoms posed by the dynamic component can be reduced to a minimum by pharmacologic blockade of the alpha-adrenergic receptors. Alpha-blockade can also reduce irritative symptoms. Acute obstruction due to overstimulation of alpha-receptors can be relieved or prevented by alpha-blockade.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462300

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients.

Authors:  Tong Zhang; Haihu Wu; Shuai Liu; Wei He; Kejia Ding
Journal:  Int Urol Nephrol       Date:  2017-04-13       Impact factor: 2.370

Review 2.  Medical treatment of benign prostatic hyperplasia.

Authors:  Stephen S Connolly; John M Fitzpatrick
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

3.  Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling.

Authors:  Xinhua Zhang; Ning Zang; Yu Wei; Jin Yin; Ruobing Teng; Allen Seftel; Michael E Disanto
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-25       Impact factor: 4.310

4.  Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans.

Authors:  J Vincent; W Dachman; T F Blaschke; B B Hoffman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells.

Authors:  Xi Han; Yang Liu; Wendy R Kam; David A Sullivan
Journal:  Exp Eye Res       Date:  2018-02-13       Impact factor: 3.467

6.  The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types.

Authors:  J Tseng-Crank; T Kost; A Goetz; S Hazum; K M Roberson; J Haizlip; N Godinot; C N Robertson; D Saussy
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

7.  Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia.

Authors:  Hyoung Woo Kim; Dae Geun Moon; Hyun Min Kim; Jong Ho Hwang; Soon Chan Kim; Sam Geuk Nam; Jun Tag Park
Journal:  Korean J Urol       Date:  2011-10-19

8.  Inhibitory effects of Nigella sativa seed oil on the testosterone-induced benign prostatic hyperplasia in rats.

Authors:  Arezo Sadeghimanesh; Sajedeh Gholipour; Akram Torki; Hossein Amini-Khoei; Zahra Lorigooini; Solomon Habtemariam
Journal:  Biomedicine (Taipei)       Date:  2021-03-01

9.  Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction.

Authors:  J V Partin; I E Anglin; N Kyprianou
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

10.  The expression and functional activities of smooth muscle myosin and non-muscle myosin isoforms in rat prostate.

Authors:  Ping Chen; Jing Yin; Yu-Ming Guo; He Xiao; Xing-Huan Wang; Michael E DiSanto; Xin-Hua Zhang
Journal:  J Cell Mol Med       Date:  2017-10-09       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.